Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3843746 | Actas Urológicas Españolas | 2012 | 12 Pages |
Abstract
In the treatment of localised invasive bladder cancer (BCa), the standard treatment remains radical surgical removal of the bladder within standard limits, including as-yet-unspecified regional lymph nodes. However, the addition of neoadjuvant chemotherapy must be considered for certain specific patient groups. A new drug for second-line chemotherapy (vinflunine) in metastatic disease has been approved and is recommended.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
A. Stenzl, N.C. Cowan, M. De Santis, M.A. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes,